Legato Capital Management’s Amedisys AMED Stock Holding History

Legato Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,879	Closed	-$874K	–	563
2025 Q2	$874K	Hold	8,879	–	–	0.1%	312
2025 Q1	$822K	Sell	8,879 -109	-1%	-$10K	0.11%	305
2024 Q4	$816K	Hold	8,988	–	–	0.11%	332
2024 Q3	$867K	Hold	8,988	–	–	0.11%	342
2024 Q2	$825K	Hold	8,988	–	–	0.11%	310
2024 Q1	$828K	Hold	8,988	–	–	0.1%	324
2023 Q4	$854K	Hold	8,988	–	–	0.11%	302
2023 Q3	$839K	Sell	8,988 -352	-4%	-$32.5K	0.12%	285
2023 Q2	$854K	Hold	9,340	–	–	0.12%	293
2023 Q1	$687K	Buy	9,340 +2,368	+34%	+$205K	0.12%	274
2022 Q4	$582K	Buy	+6,972	New	+$629K	0.11%	296

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Legato Capital Management's AMED Position: Q3 2025 in Review

Legato Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 8,879 shares — an estimated $874K sold.

Legato Capital Management first reported a position in AMED in Q4 2022 and held it in 11 quarters. The position peaked at $874K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Legato Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Legato Capital Management sold 8,879 Amedisys shares in Q3 2025, an estimated $874K.
Legato Capital Management first reported a position in Amedisys in Q4 2022 and held it in 11 quarters.
Legato Capital Management's Amedisys position peaked at $874K in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Legato Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.